Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Mütze, Ulrike [VerfasserIn]   i
 Walter, Magdalena [VerfasserIn]   i
 Keller, Mareike [VerfasserIn]   i
 Gramer, Gwendolyn [VerfasserIn]   i
 Garbade, Sven [VerfasserIn]   i
 Gleich, Florian [VerfasserIn]   i
 Haas, Dorothea [VerfasserIn]   i
 Posset, Roland [VerfasserIn]   i
 Grünert, Sarah C. [VerfasserIn]   i
 Hennermann, Julia B. [VerfasserIn]   i
 Thimm, Eva [VerfasserIn]   i
 Fang-Hoffmann, Junmin [VerfasserIn]   i
 Syrbe, Steffen [VerfasserIn]   i
 Okun, Jürgen G. [VerfasserIn]   i
 Hoffmann, Georg F. [VerfasserIn]   i
 Kölker, Stefan [VerfasserIn]   i
Titel:Health outcomes of infants with vitamin B12 deficiency identified by newborn screening and early treated
Verf.angabe:Ulrike Mütze, MD, Magdalena Walter, PhD, Mareike Keller, MSc, Gwendolyn Gramer, MD, Sven F. Garbade, PhD,Florian Gleich, Dipl.-Vw., Dorothea Haas, MD, Roland Posset, MD, Sarah C. Grünert, MD, Julia B. Hennermann, MD,Eva Thimm, MD, Junmin Fang-Hoffmann, MD, Steffen Syrbe, MD, Jürgen G. Okun, PhD, Georg F. Hoffmann, MD, and Stefan Kölker, MD
E-Jahr:2021
Jahr:11 February 2021
Umfang:7 S.
Fussnoten:Im Titel ist die Zahl 12 tiefgestellt ; Gesehen am 29.09.2021
Titel Quelle:Enthalten in: The journal of pediatrics
Ort Quelle:St. Louis, Mo. : Mosby, 1932
Jahr Quelle:2021
Band/Heft Quelle:235(2021) vom: Aug., Seite 42-48
ISSN Quelle:1097-6833
Abstract:Objective - To evaluate the clinical outcomes at age 1.5 ± 0.5 years of infants with vitamin B12 deficiency identified by newborn screening (NBS). - Study design - Prospective multicenter observational study on health outcomes of 31 infants with vitamin B12 deficiency identified by NBS. Neurodevelopment was assessed by the Denver Developmental Screening Test. - Results - In 285 862 newborns screened between 2016 and 2019, the estimated birth prevalence of vitamin B12 deficiency was 26 in 100 000 newborns, with high seasonal variations (lowest in summer: 8 in 100 000). Infants participating in the outcome study (N = 31) were supplemented with vitamin B12 for a median (range) of 5.9 (1.1-16.2) months. All achieved age-appropriate test results in Denver Developmental Screening Test at age 15 (11-23) months and did not present with symptoms characteristic for vitamin B12 deficiency. Most (81%, n = 25) mothers of affected newborns had a hitherto undiagnosed (functional) vitamin B12 deficiency, and, subsequently, received specific therapy. - Conclusions - Neonatal vitamin B12 deficiency can be screened by NBS, preventing the manifestation of irreversible neurologic symptoms and the recurrence of vitamin B12 deficiency in future pregnancies through adequate treatment of affected newborns and their mothers. The high frequency of mothers with migrant background having a newborn with vitamin B12 deficiency highlights the need for improved prenatal care.
DOI:doi:10.1016/j.jpeds.2021.02.009
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.jpeds.2021.02.009
 Volltext: https://www.sciencedirect.com/science/article/pii/S0022347621001189
 DOI: https://doi.org/10.1016/j.jpeds.2021.02.009
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:cobalamin deficiency
 neonatal screening
 neurocognitive outcome
K10plus-PPN:1772057681
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68784520   QR-Code
zum Seitenanfang